Abstract:Abstract The August 2023 article in Science Signaling, “TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis,” challenges the traditional M1/M2 macrophage classification by investigating the impact of transforming growth factor β on macrophage metabolism and function. Despite its conventional anti-inflammatory role, transforming growth factor β–treated macrophages exhibit a distinct phenotype marked by heightened glycolysis, suppressed proinflammatory cytokines, and increased coagulation factor expression. The study identifies phosphofructokinase, liver type as a crucial glycolytic enzyme regulated by transforming growth factor β via the mTOR–c-MYC pathway. Epigenetic changes induced by transforming growth factor β, such as increased Smad3 activation and reduced proinflammatory transcription factor motif enrichment, contribute to the anti-inflammatory profile. The research extends its implications to sepsis, revealing the role of transforming growth factor β in exacerbating coagulation and reducing survival in mouse models. This effect involves upregulation of coagulation factor F13A1, dependent on phosphofructokinase, liver type activity and glycolysis in macrophages. Connections to COVID-19 pathology are drawn, as transforming growth factor β–treated macrophages and SARS-CoV-2 E protein-exposed cells display similar metabolic profiles. Bioinformatic analysis of COVID-19 patient data suggests correlations between myeloid expression of TGFβR1, PFKL, and F13A1 with disease severity. The study challenges the M1/M2 classification, emphasizing the complexity of macrophage responses influenced by transforming growth factor β, proposing transforming growth factor β as a potential therapeutic target for conditions like sepsis and COVID-19 where dysregulated coagulation is significant. Overall, the research provides valuable insights into transforming growth factor β–mediated immunometabolic regulation, paving the way for future investigations and potential therapeutic interventions.

Macrophage Function and the Role of GSK3

Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr-/- Macrophages

Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases

Glycogen synthase kinase-3: functions in oncogenesis and development

Metabolic Regulation of Macrophage Activation

Metabolic Modulation in Macrophage Effector Function

Intracellular Methylglyoxal Accumulation in Classically Activated Mouse Macrophages is Mediated by HIF-1α

Glycogen synthase kinase 3 in Wnt signaling pathway and cancer

Regulation mechanism of PDK1 on macrophage metabolism and function

Control of macrophage metabolism and activation by mTOR and Akt signaling

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

The Key Roles of GSK-3β in Regulating Mitochondrial Activity

Metabolic reprogramming in macrophage responses

Glycogen metabolism regulates macrophage-mediated acute inflammatory responses

GSK3 is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target

Glycogen synthase kinase-3 is essential for Treg development and function

Macrophages in Immunoregulation and Therapeutics

GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model

Metabolism of tissue macrophages in homeostasis and pathology

Glycogen synthase kinase-3 (GSK3): Regulation, actions and diseases.

TGFβ macrophage reprogramming: a new dimension of macrophage plasticity